Atlas market file · Equity · United States
RF Acquisition Corp IIIRFAM
- Last close
- 9.91
- Change
- +0.20%
- 96-bar range
- 9.77 – 9.94
- As of
- 6 Aug 2026
RF Acquisition Corp III is a blank checks issuer listed as RFAM on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 25 weekly closes (+0.71% over the window).
Source rail: Yahoo Finance chart API (RFAM). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for RFAM. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
RFAM public profile
Blank checks issuer. RF Acquisition Corp III is connected to current market context, cited company sources and its retained research file.
RF Acquisition Corp III trades as RFAM on NASDAQ. RF Acquisition Corp III (RFAM) has a latest verified close of 9.91, up 0.20%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files RFAM under USA Stocks for browsing.
What changed for RF Acquisition Corp III today
RF Acquisition Corp III (RFAM) has signed a Business Combination Agreement with HCC Healthcare Pte. Ltd., a private company based in Singapore (source: Press Release, dated July 9, 2026, https://www.sec.gov/Archives/edgar/data/2091712/000182912626007475/rfacquisition3_ex99-1.htm). The transaction, expected to close in the fourth quarter of 2026, is subject to shareholder approval and regulatory filings.
RFAM is a special purpose acquisition company (SPAC) with $102.2 million in assets and $349,808 in liabilities as of June 30, 2026 (source: 10-Q, period ending 2026-06-30, https://www.sec.gov/Archives/edgar/data/2091712/000182912626007711/rfacquisitioncorp3_10q.htm). Its operating income for the same period was $-303,527, indicating significant operational challenges.
For the period ending June 30, 2026, RFAM reported a net income (loss) attributable to parent of $566,737 and stockholders' equity attributable to parent of $595,740 (source: 10-Q, period ending 2026-06-30, https://www.sec.gov/Archives/edgar/data/2091712/000182912626007711/rfacquisitioncorp3_10q.htm). The company's cash and cash equivalents stood at $891,600, while net cash used in operating activities was $-209,974.
The Business Combination Agreement and related transactions were approved by the boards of directors of RFAM, HCC Healthcare, and Merger Sub (source: Business Combination Agreement, dated as of July 9, 2026, https://www.sec.gov/Archives/edgar/data/2091712/000182912626007475/rfacquisition3_ex2-1.htm). The agreement includes contracts involving obligations, payments, or revenues in excess of $250,000 in the last twelve months or expected to exceed $250,000 in the next twelve months.
The Founder’s Support and Lock-Up Agreement ensures that key stakeholders are committed to the transaction, with restrictions on engaging in discussions or negotiations with other potential acquirers (source: Founder’s Support and Lock-Up Agreement and Deed, dated as of July 9, 2026, https://www.sec.gov/Archives/edgar/data/2091712/000182912626007475/rfacquisition3_ex10-2.htm).
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
RFAM technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on RFAM
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep RFAM research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
RFAM FAQ
What is RF Acquisition Corp III (RFAM)?RF Acquisition Corp III (RFAM) has a latest verified close of 9.91, up 0.20%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed...
RF Acquisition Corp III (RFAM) has a latest verified close of 9.91, up 0.20%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for RFAM?RF Acquisition Corp III (RFAM) has a latest verified close of 9.91, up 0.20%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources,...
RF Acquisition Corp III (RFAM) has a latest verified close of 9.91, up 0.20%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files RFAM under USA Stocks for browsing.
How often is the RFAM page updated?The RFAM public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The RFAM public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for RFAM?The RFAM file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:RFAM. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The RFAM file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:RFAM. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on RFAM?Yes. The workstation can open RFAM, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open RFAM, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this RFAM page investment advice?No. The RFAM page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The RFAM page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
RFAM
Equity · evidence first